Neurology · 510(k) · 2021
EYE-SYNC
SyncThink, Inc.. Cleared by FDA on 2 October 2021 under submission K202927, product code QEA (brain injury adjunctive interpretive oculomotor assessment aid). What FDA's record says, in FDA's words.
Device record · K202927
- Device. EYE-SYNCDEVICE
- Company. SyncThink, Inc.COMPANY
- Decision. 2 October 2021, 510(k), substantially equivalent (traditional review); received 29 September 2020DECISION
- Panel. NeurologyPANEL
- Product code. QEA, Brain Injury Adjunctive Interpretive Oculomotor Assessment AidCODE
- Regulation. 21 CFR 882.1455, Class IIREG
- Source. FDA database entry · decision document (11 pages)SOURCE
Retrieved · the fields above are FDA's; the statement below was copied from the decision document on that day.
What FDA cleared it for
The Indications for Use statement, verbatim, from the decision document.
The EYE-SYNC is intended for recording, viewing, and analyzing eye movements in support of identifying visual tracking impairment in human subjects. The EYE-SYNC is intended to record, measure, and analyze eye movements as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI), within three days of sport-related head injury in 2 patients 17 -24 years of age in conjunction with a standard neurological assessment, for use by medical professionals qualified to interpret the results of a concussion assessment examination. A negative EYE-SYNC classification corresponds to eye movements that are consistent with a lack of concussion. A positive EYE-SYNC classification corresponds to eye movements that may be present in patients with concussion.
The product code's definition, from FDA's classification record. A traumatic brain injury eye movement assessment aid is a prescription device that uses a patients tracked eye movements to provide an interpretation of the functional condition of the patients brain. This device is an assessment aid that is not intended for standalone detection or diagnostic purposes.
What the statement says
Pattern matches on the Indications for Use text. Each line is a fact that the text contains the words, not a finding about the device.
- Mentionsdetection or identification of findings
- Mentionsmeasurement or quantification
- Mentionsa diagnostic claim
Adverse-event reports in MAUDE, by product code
As of , MAUDE held 0 reports filed against devices carrying product code QEA. That code is shared by every device of this type, not this device alone, and MAUDE reports are submitted by manufacturers, facilities and the public without FDA verification.
Where this fits
This page is a record, not medical advice and not a safety rating. It copies FDA's fields and FDA's statement, and lists what the statement's text mentions. Read the labeling before relying on any of it.
More devices under product code QEA, in Neurology, or cleared in 2021. The whole record is at FDA AI-enabled medical devices.
A device's authorized use is a sentence the record can be read against. What Apodicta does on a medical record is that reading: every line of a note, a claim or a report proved to its source or held, before it renders.